Advocacy and Stakeholder Engagement
Indivior Patient Help Foundation
In 2018, Indivior continued engaging with stakeholders and advocating for patients to help stimulate and accelerate changes to public policy. In the US, Indivior supported the passage of H.R.6, the SUPPORT for Patients and Communities Act. Indivior’s Chief Medical Officer testified on behalf of the Group before the US House of Representatives Energy and Commerce Subcommittee on Health hearing on ‘Combating the Opioid Crisis: Helping Communities Balance Enforcement and Patient Safety’. This hearing helped establish the policies ultimately included in H.R.6. ‘‘New innovations are expanding medication-assisted treatment options,” the Chief Medical Officer stated during her testimony. “Government policies impacting these treatments must adapt to ensure patients have access to all evidence-based treatment options.”
Enacted on October 24, 2018, this law includes multiple, comprehensive initiatives to improve access to treatment for patients suffering from substance use disorders.
The Chief Medical Officer also participated in the US State Government Affairs Council Leaders Policy Conference on Innovations in Healthcare panel entitled ‘Revolutionary Treatments for Society’ in 2018. At the conference, she underscored the importance of understanding the patient journey and giving patients and their healthcare providers access to the full range of evidence-based therapies.
In 2018, Indivior also supported a range of non-governmental agencies and campaigns around the world to help destigmatize and raise awareness of the disease of addiction and other mental health disorders. Indivior also supported efforts to develop resources for patients, families and communities.